Spain has allowed the medication of medical cannabis derivatives for the treatment of spasticity in patients with multiple sclerosis.
Spain’s health minister Trinidad Jimenez said “the therapeutic use of cannabis has been studied for many years and is well-documented in clinical trials” (The trials that have been allowed that is, evidence has been there for years of course and getting approval in most countries is still difficult.).
The use of cannabis to help with the symptoms of different ailments and medical conditions is a very controversial subject to some (mainly the idiots in power), but what is certain is that some patients with illnesses that involve chronic pain often have turned to medical cannabis to alleviate their suffering.
People diagnosed with multiple sclerosis and experiencing moderate to chronic muscle spasms can get a prescription for the cannabis-based drug, Sativex, which is administered as an oral spray.
The health minister ruled out that the medical use of cannabis will be extended to other ailments, for instance cancer. (At this point now I presume)
She clarified that this was about a very specific use, if other treatments have failed, if and when authorised by a medical specialist and for a very small number of patients. (I suspect that will be a growing list)
Meanwhile, GW Pharmaceuticals the makers of Sativex have begun applying for approval in other European Union member countries Germany, France and Italy.
GD Star Rating
loading...